Somaiah, N., Chawla, S. P., Block, M. S., Morris, J. C., Do, K., Kim, J. W., . . . Pollack, S. M. (2020). A Phase 1b Study Evaluating the Safety, Tolerability, and Immunogenicity of CMB305, a Lentiviral-Based Prime-Boost Vaccine Regimen, in Patients with Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1. Oncoimmunology.
Citação norma ChicagoSomaiah, Neeta, et al. "A Phase 1b Study Evaluating the Safety, Tolerability, and Immunogenicity of CMB305, a Lentiviral-Based Prime-Boost Vaccine Regimen, in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1." Oncoimmunology 2020.
Citação norma MLASomaiah, Neeta, et al. "A Phase 1b Study Evaluating the Safety, Tolerability, and Immunogenicity of CMB305, a Lentiviral-Based Prime-Boost Vaccine Regimen, in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1." Oncoimmunology 2020.